The observations in this study that enhanced expression of Gli1 and/or Gli2 occurs in these RMS cells provide a tempting scenario to investigate the role of Gli1/2 as molecular target for blocking pathogenesis of these deadly children's cancers since it is known that high expression of GLIs may also have severe consequences in attaining resistance to certain therapeutic modalities. This evidence concerns the gene GLI2 and cancer.